Suppr超能文献

罕见病中的多系统表现:先天性角化不良症的经验。

Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita.

机构信息

Pediatric Dentistry and Special Dental Care Unit, Meyer Children's University Hospital, 50139 Florence, Italy.

Unit of Metabolism, Bambino Gesù Children's Research Hospital, Piazza Sant'Onofrio, 4, 00165 Rome, Italy.

出版信息

Genes (Basel). 2022 Mar 11;13(3):496. doi: 10.3390/genes13030496.

Abstract

Dyskeratosis congenital (DC) is the first genetic syndrome described among telomeropathies. Its classical phenotype is characterized by the mucocutaneous triad of reticulated pigmentation of skin lace, nail dystrophy and oral leukoplakia. The clinical presentation, however, is heterogeneous and serious clinical complications include bone marrow failure, hematological and solid tumors. It may also involve immunodeficiencies, dental, pulmonary and liver disorders, and other minor complication. Dyskeratosis congenita shows marked genetic heterogeneity, as at least 14 genes are responsible for the shortening of telomeres characteristic of this disease. This review discusses clinical characteristics, molecular genetics, disease evolution, available therapeutic options and differential diagnosis of dyskeratosis congenita to provide an interdisciplinary and personalized medical assessment that includes family genetic counseling.

摘要

先天性角化不良(DC)是首个在端粒病中描述的遗传综合征。其典型表型的特征是皮肤花边状网状色素沉着、指甲营养不良和口腔白斑的黏膜皮肤三联征。然而,临床表现具有异质性,严重的临床并发症包括骨髓衰竭、血液系统和实体瘤。它也可能涉及免疫缺陷、牙齿、肺部和肝脏疾病以及其他较小的并发症。先天性角化不良表现出明显的遗传异质性,因为至少有 14 个基因负责缩短这种疾病特征的端粒。这篇综述讨论了先天性角化不良的临床特征、分子遗传学、疾病进展、可用的治疗选择和鉴别诊断,以提供包括家族遗传咨询在内的跨学科和个性化的医学评估。

相似文献

1
Multisystemic Manifestations in Rare Diseases: The Experience of Dyskeratosis Congenita.
Genes (Basel). 2022 Mar 11;13(3):496. doi: 10.3390/genes13030496.
2
Dyskeratosis congenita: presentation of cutaneous triad in a sporadic case.
BMJ Case Rep. 2018 Nov 28;11(1):e226736. doi: 10.1136/bcr-2018-226736.
3
Recent progress in dyskeratosis congenita.
Int J Hematol. 2010 Oct;92(3):419-24. doi: 10.1007/s12185-010-0695-5. Epub 2010 Oct 1.
4
[Research progress of dyskeratosis congenita].
Zhonghua Kou Qiang Yi Xue Za Zhi. 2019 Feb 9;54(2):130-134. doi: 10.3760/cma.j.issn.1002-0098.2019.02.010.
5
Dyskeratosis congenita associated with leukoplakia of the tongue.
Int J Oral Maxillofac Surg. 2016 Jun;45(6):760-3. doi: 10.1016/j.ijom.2015.12.005. Epub 2016 Jan 5.
6
Liver Transplant for Management of Hepatic Complications of Dyskeratosis Congenita: A Case Report.
Exp Clin Transplant. 2022 Jul;20(7):702-705. doi: 10.6002/ect.2020.0073. Epub 2020 Nov 27.
7
Malignant transformation of oral leukoplakia in a patient with dyskeratosis congenita.
Oral Surg Oral Med Oral Pathol Oral Radiol. 2017 Oct;124(4):e239-e242. doi: 10.1016/j.oooo.2017.08.001. Epub 2017 Aug 12.
8
Dyskeratosis congenita.
Hematol Oncol Clin North Am. 2009 Apr;23(2):215-31. doi: 10.1016/j.hoc.2009.01.003.
9
Biallelic TERT variant leads to Hoyeraal-Hreidarsson syndrome with additional dyskeratosis congenita findings.
Am J Med Genet A. 2022 Apr;188(4):1226-1232. doi: 10.1002/ajmg.a.62602. Epub 2021 Dec 9.
10
Dyskeratosis congenita vs. chronic graft versus host disease: report of a case and a review of the literature.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2004 Nov;98(5):566-71. doi: 10.1016/j.tripleo.2004.01.011.

引用本文的文献

3
Presumptive Cytomegalovirus Retinitis as a Complication of Dyskeratosis Congenita: A Case Report.
Case Rep Ophthalmol. 2024 Jul 24;15(1):572-576. doi: 10.1159/000540221. eCollection 2024 Jan-Dec.
4
[Progeroid syndromes : Aging, skin aging, and mechanisms of progeroid syndromes].
Dermatologie (Heidelb). 2023 Sep;74(9):696-706. doi: 10.1007/s00105-023-05212-8. Epub 2023 Aug 31.
5
Telomere biology: from disorders to hematological diseases.
Front Oncol. 2023 May 19;13:1167848. doi: 10.3389/fonc.2023.1167848. eCollection 2023.
6
Case report: A novel mutation in gene in dyskeratosis congenita.
Front Oncol. 2023 Mar 2;13:1098876. doi: 10.3389/fonc.2023.1098876. eCollection 2023.
7
The role of liver transplantation in the care of primary hepatic vascular tumours in children.
Front Oncol. 2022 Nov 24;12:1026232. doi: 10.3389/fonc.2022.1026232. eCollection 2022.
8
Exploring deep learning methods for recognizing rare diseases and their clinical manifestations from texts.
BMC Bioinformatics. 2022 Jul 6;23(1):263. doi: 10.1186/s12859-022-04810-y.

本文引用的文献

2
Dyskeratosis congenita and squamous cell carcinoma of the mandibular alveolar ridge.
BMJ Case Rep. 2021 May 11;14(5):e242459. doi: 10.1136/bcr-2021-242459.
3
Brain imaging features of children with Hoyeraal-Hreidarsson syndrome.
Brain Behav. 2021 May;11(5):e02079. doi: 10.1002/brb3.2079. Epub 2021 Mar 18.
4
Multiple bilateral hip fractures in a patient with dyskeratosis congenita caused by a novel mutation in the PARN gene.
Osteoporos Int. 2021 Jun;32(6):1227-1231. doi: 10.1007/s00198-020-05758-6. Epub 2020 Nov 27.
5
Revesz syndrome revisited.
Orphanet J Rare Dis. 2020 Oct 23;15(1):299. doi: 10.1186/s13023-020-01553-y.
6
Coats plus syndrome (cerebroretinal microangiopathy with calcifications and cysts-1): A case report.
Pediatr Dermatol. 2021 Jan;38(1):191-193. doi: 10.1111/pde.14366. Epub 2020 Oct 3.
8
Gastrointestinal Hemorrhage: A Manifestation of the Telomere Biology Disorders.
J Pediatr. 2021 Mar;230:55-61.e4. doi: 10.1016/j.jpeds.2020.09.038. Epub 2020 Sep 21.
9
Dyskeratosis congenita: a literature review.
J Dtsch Dermatol Ges. 2020 Sep;18(9):943-967. doi: 10.1111/ddg.14268. Epub 2020 Sep 15.
10
Acute depletion of telomerase components DKC1 and NOP10 induces oxidative stress and disrupts ribosomal biogenesis via NPM1 and activation of the P53 pathway.
Biochim Biophys Acta Mol Cell Res. 2020 Dec;1867(12):118845. doi: 10.1016/j.bbamcr.2020.118845. Epub 2020 Sep 7.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验